A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19

The development of effective countermeasures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the COVID-19 pandemic, is a priority. We designed and produced ConVac, a replication-competent vesicular stomatitis virus (VSV) vaccine vector that expresses t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Vaccines
Autors principals: Malherbe, Delphine C., Kurup, Drishya, Wirblich, Christoph, Ronk, Adam J., Mire, Chad, Kuzmina, Natalia, Shaik, Noor, Periasamy, Sivakumar, Hyde, Matthew A., Williams, Julie M., Shi, Pei-Yong, Schnell, Matthias J., Bukreyev, Alexander
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8298481/
https://ncbi.nlm.nih.gov/pubmed/34294728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00352-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars